EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION

Objective: to assess the efficacy, safety and tolerability of the new combined medication Allergoferon® beta in patients with moderate-to-severe hay fever (seasonal allergic rhinitis and conjunctivitis) during periods of exacerbation. patients and methods: the object of our study was medication Alle...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: A. A. Ryabtseva, N. Y. Sotnikova, O. V. Chumikov, N. A. Stupakova
Natura: Artigo
Lingua:Russo
Pubblicazione: Ophthalmology Publishing Group 2016-09-01
Serie:Oftalʹmologiâ
Soggetti:
hay fever
efficacy
safety
recombinant interferon
betamethasone
allergoferon® beta
Accesso online:https://www.ophthalmojournal.com/opht/article/view/324
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi